Authors:
AUDINOT V
NEWMANTANCREDI A
GOBERT A
RIVET JM
BROCCO M
LEJEUNE F
GLUCK L
DESPOSTE I
BERVOETS K
DEKEYNE A
MILLAN MJ
Citation: V. Audinot et al., A COMPARATIVE IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL DOPAMINE D-3 RECEPTOR ANTAGONISTS (-S-14297, NAFADOTRIDE, GR-103,691 AND U-99194()), The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 187-197
Authors:
MILLAN MJ
SCHREIBER R
DEKEYNE A
RIVET JM
BERVOETS K
MAVRIDIS M
SEBBAN C
MAURELREMY S
NEWMANTANCREDI A
SPEDDING M
MULLER O
LAVIELLE G
BROCCO M
Citation: Mj. Millan et al., S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL, POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - II - FUNCTIONAL PROFILE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL, The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1356-1373
Authors:
MILLAN MJ
BROCCO M
VEIGA S
CISTARELLI L
MELON C
GOBERT A
Citation: Mj. Millan et al., WAY-100,635 ENHANCES BOTH THE ANTIDEPRESSANT ACTIONS OF DULOXETINE AND ITS INFLUENCE ON DIALYSATE LEVELS OF SEROTONIN IN FRONTAL-CORTEX, European journal of pharmacology, 341(2-3), 1998, pp. 165-167
Authors:
MILLAN MJ
NEWMANTANCREDI A
RIVET JM
BROCCO M
LACROIX P
AUDINOT V
CISTARELLI L
GOBERT A
Citation: Mj. Millan et al., S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .1. INTERACTION WITH CLONED HUMAN (H)5-HT1A, DOPAMINE HD(2) HD(3) AND H-ALPHA(2A)-ADRENERGIC RECEPTORS IN RELATION TO MODULATION OF CORTICAL MONOAMINE RELEASE AND ACTIVITY IN MODELS OF POTENTIAL ANTIDEPRESSANT ACTIVITY/, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 132-147
Authors:
MILLAN MJ
HJORTH S
SAMANIN R
SCHREIBER R
JAFFARD R
DELADONCHAMPS B
VEIGA S
GOUMENT B
PEGLION JL
SPEDDING M
BROCCO M
Citation: Mj. Millan et al., S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .2. MODULATION OF HIPPOCAMPAL SEROTONIN RELEASE IN RELATION TO POTENTIAL ANXIOLYTIC PROPERTIES, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 148-161
Citation: Mj. Millan et al., THE DOPAMINE-D-3-RECEPTOR ANTAGONIST, (-S-14297, BLOCKS THE CATALEPTIC PROPERTIES OF HALOPERIDOL IN RATS()), European journal of pharmacology, 321(3), 1997, pp. 7-9
Authors:
CARRIZO ME
ROMERO JM
MIOZZO MC
BROCCO M
PANZETTA P
CURTINO JA
Citation: Me. Carrizo et al., BIOSYNTHESIS OF PROTEOGLYCOGEN - MODULATION OF GLYCOGENIN EXPRESSION IN THE DEVELOPING CHICKEN, Biochemical and biophysical research communications, 240(1), 1997, pp. 142-145
Authors:
SCHREIBER R
BROCCO M
DELADONCHAMPS BL
MILLAN MJ
Citation: R. Schreiber et al., INVOLVEMENT OF 5-HT1A RECEPTORS IN THE ANXIOLYTIC ACTION OF S-14671 IN THE PIGEON CONFLICT TEST, Pharmacology, biochemistry and behavior, 51(2-3), 1995, pp. 211-215
Authors:
SCHREIBER R
BROCCO M
DELADONCHAMPS BL
MONNEYRON S
MILLAN MJ
Citation: R. Schreiber et al., A DRUG DISCRIMINATION ANALYSIS OF THE ACTIONS OF NOVEL SEROTONIN(1A) RECEPTOR LIGANDS IN THE RAT USING THE 5-HT1A RECEPTOR AGONIST, 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 822-831
Authors:
MILLAN MJ
PEGLION JL
VIAN J
RIVET JM
BROCCO M
GOBERT A
NEWMANTANCREDI A
DACQUET C
BERVOETS K
GIRARDON S
JACQUES V
CHAPUT C
AUDINOT V
Citation: Mj. Millan et al., FUNCTIONAL CORRELATES OF DOPAMINE D-3 RECEPTOR ACTIVATION IN THE RAT IN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .1. ACTIVATION OF POSTSYNAPTIC D-3, RECEPTORS MEDIATES HYPOTHERMIA, WHEREAS BLOCKADE OF D-2 RECEPTORS ELICITS PROLACTIN SECRETION AND CATALEPSY()), The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 885-898
Authors:
MILLAN MJ
RIVET JM
AUDINOT V
GOBERT A
LEJEUNE F
BROCCO M
NEWMANTANCREDI A
MAURELREMY S
BERVOETS K
Citation: Mj. Millan et al., ANTAGONIST PROPERTIES OF LY-165,163 AT PRESYNAPTIC AND POSTSYNAPTIC DOPAMINE D-2, D-3, AND D-1 RECEPTORS - MODULATION OF AGONIST ACTIONS AT5-HT1A RECEPTORS IN-VIVO, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1418-1427
Authors:
SCHREIBER R
BROCCO M
AUDINOT V
GOBERT A
VEIGA S
MILLAN MJ
Citation: R. Schreiber et al., (1-(2,5-DIMETHOXY-4 IODOPHENYL)-2-AMINOPROPANE)-INDUCED HEAD-TWITCHESIN THE RAT ARE MEDIATED BY 5-HYDROXYTRYPTAMINE (5-HT)(2A) RECEPTORS -MODULATION BY NOVEL 5-HT2A 2C ANTAGONISTS, D-1 ANTAGONISTS AND 5-HT1AAGONISTS/, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 101-112
Authors:
PEGLION JL
CANTON H
BERVOETS K
AUDINOT V
BROCCO M
GOBERT A
LEMAROUILLEGIRARDON S
MILLAN MJ
Citation: Jl. Peglion et al., CHARACTERIZATION OF POTENT AND SELECTIVE ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS IN A SERIES OF N4-SUBSTITUTED ARYLPIPERAZINES, Journal of medicinal chemistry, 38(20), 1995, pp. 4044-4055
Authors:
MILLAN MJ
AUDINOT V
BROCCO M
MAURELREMY S
JOLY F
NEWMANTANCREDI A
CANTON H
HAUTEFAYE P
SPEDDING M
MULLER O
LAVIELLE G
Citation: Mj. Millan et al., S-16924 - A PYRROLIDINE-SUBSTITUTED BENZODIOXANE WITH HIGHER AFFINITYAT 5-HT1A 2A/2C THAN D2 RECEPTORS, AND AN ATYPICAL ANTIPSYCHOTIC PROFILE IN THE RAT/, British Journal of Pharmacology, 114, 1995, pp. 156-156
Authors:
MILLAN MJ
CANTON H
GOBERT A
LEJEUNE F
RIVET JM
BERVOETS K
BROCCO M
WIDDOWSON P
MENNINI T
AUDINOT V
HONORE P
RENOUARD A
LEMAROUILLEGIRARDON S
VERRIELE L
GRESSIER H
PEGLION JL
Citation: Mj. Millan et al., NOVEL BENZODIOXOPIPERAZINES ACTING AS ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS AND AS AGONISTS AT 5-HT1A AUTORECEPTORS - A COMPARATIVE PHARMACOLOGICAL CHARACTERIZATION WITH PROPOSED 5-HT1A ANTAGONISTS, The Journal of pharmacology and experimental therapeutics, 268(1), 1994, pp. 337-352
Authors:
SCHREIBER R
BROCCO M
GOBERT A
VEIGA S
MILLAN MJ
Citation: R. Schreiber et al., THE POTENT ACTIVITY OF THE 5-HT1A RECEPTOR AGONISTS, S-14506 AND S-14671, IN THE RAT FORCED SWIM TEST IS BLOCKED BY NOVEL 5-HT1A-RECEPTOR ANTAGONISTS, European journal of pharmacology, 271(2-3), 1994, pp. 537-541
Citation: R. Schreiber et al., BLOCKADE OF THE DISCRIMINATIVE STIMULUS EFFECTS OF DOI BY MDL-100,907AND THE ATYPICAL ANTIPSYCHOTICS, CLOZAPINE AND RISPERIDONE, European journal of pharmacology, 264(1), 1994, pp. 99-102